Stockscreener 앱 받기
10.45
5.09%
-0.56
전일 마감가:
$11.01
열려 있는:
$10.96
하루 거래량:
721.32K
Relative Volume:
1.25
시가총액:
$430.72M
수익:
$324.01M
순이익/손실:
$-192.37M
주가수익비율:
-2.1862
EPS:
-4.78
순현금흐름:
$-23.46M
1주 성능:
+5.98%
1개월 성능:
-22.48%
6개월 성능:
+21.51%
1년 성능:
-18.17%
1일 변동 폭
$10.39
$11.10
1주일 범위
$9.72
$11.10
52주 변동 폭
$8.27
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
명칭
Angiodynamic Inc
전화
(518) 798-1215
주소
14 PLAZA DRIVE, LATHAM
ANGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
10.45 | 453.80M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 개시 | Lake Street | Buy |
| 2024-04-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 개시 | H.C. Wainwright | Buy |
| 2023-04-17 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 개시 | Oppenheimer | Perform |
| 2020-11-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2017-04-07 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-03-30 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 개시 | Barclays | Equal Weight |
| 2016-11-04 | 개시 | Cantor Fitzgerald | Buy |
| 2016-04-08 | 재개 | Piper Jaffray | Neutral |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 재확인 | Canaccord Genuity | Hold |
| 2012-06-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | 업그레이드 | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2010-09-08 | 재확인 | Wedbush | Neutral |
모두보기
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView — Track All Markets
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - Times Union
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
How AngioDynamics Inc. stock reacts to oil pricesJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Earnings Beat: Why AngioDynamics Inc. stock is seen as undervaluedWeekly Investment Report & Entry Point Confirmation Alerts - Улправда
Is AngioDynamics Inc. stock a defensive play in 2025Portfolio Risk Report & Low Risk Entry Point Tips - Улправда
Why AngioDynamics Inc. stock is seen as undervaluedMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Why AngioDynamics Inc. (UG2) stock remains top rated2025 Dividend Review & High Win Rate Trade Tips - Улправда
Will AngioDynamics Inc. stock benefit from commodity prices2025 Short Interest & Accurate Buy Signal Alerts - ulpravda.ru
Why AngioDynamics Inc. stock is recommended by analystsJuly 2025 Selloffs & Smart Allocation Stock Tips - Улправда
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey
AngioDynamics Q2 Earnings Call Highlights - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8% - AlphaStreet
Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - ulpravda.ru
AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Aug Decliners: Will AngioDynamics Inc stock benefit from AI adoptionBear Alert & Accurate Entry/Exit Alerts - moha.gov.vn
AngioDynamics Vortex Failure Led to Port Catheter Removal, Lawsuit - AboutLawsuits.com
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
AngioDynamics (ANGO) to Release Earnings on Tuesday - Defense World
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha
Trend Recap: Why AngioDynamics Inc UG2 stock remains top ratedTrade Exit Summary & Low Risk High Reward Trade Ideas - moha.gov.vn
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? - Yahoo Finance
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan
New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan
Why AngioDynamics Inc. stock remains on buy listsWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Will AngioDynamics Inc. stock attract more institutional investorsSwing Trade & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact AngioDynamics Inc. stockTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
How the Printed Matter Doctrine Sees Through X-Ray Markers - Patently-O
Fed. Circ. Won't Revive Bard Patents In AngioDynamics Row - Law360
Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
AngioDynamics (NASDAQ:ANGO) Stock Rating Upgraded by Wall Street Zen - Defense World
AngioDynamics' (NASDAQ:ANGO) investors will be pleased with their notable 77% return over the last year - Yahoo Finance
Dynamic Technology Lab Private Ltd Purchases Shares of 29,317 AngioDynamics, Inc. $ANGO - MarketBeat
Buyback Watch: How rising interest rates impact AngioDynamics Inc. stockTrade Risk Summary & Weekly Top Performers Watchlists - BỘ NỘI VỤ
AXQ Capital LP Has $270,000 Holdings in AngioDynamics, Inc. $ANGO - Defense World
Envestnet Asset Management Inc. Sells 172,625 Shares of AngioDynamics, Inc. $ANGO - Defense World
Will AngioDynamics Inc. (UG2) stock maintain strong growthJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
[8-K] ANGIODYNAMICS INC Reports Material Event | ANGO SEC FilingForm 8-K - Stock Titan
How strong is AngioDynamics Inc. stock balance sheetTake Profit & Low Risk High Reward Ideas - Fundação Cultural do Pará
Why AngioDynamics Inc. stock is in analyst buy zoneJuly 2025 Reactions & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
How AngioDynamics Inc. stock reacts to job market dataTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Angiodynamic Inc (ANGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Angiodynamic Inc 주식 (ANGO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Trowbridge Stephen A | EVP and CFO |
Oct 13 '25 |
Buy |
11.16 |
890 |
9,932 |
256,629 |
| Clemmer James C | President and CEO |
Oct 09 '25 |
Buy |
11.15 |
10,000 |
111,500 |
882,529 |
0.01%
1.19%
자본화:
|
볼륨(24시간):